You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Author Index Volume 50 (2016)

The issue number is given in front of the pagination

Aarsland, D., see Vallortigara, J. (1) 101–110

Aarsland, D., see Vijayaraghavan, S. (2) 567–576

Adjaye, J., see Wruck, W. (4) 1065–1082

Adluru, N., see Melah, K.E. (3) 873–886

Agamennoni, O., see Fernández, G. (3) 827–838

Agarwal, A.R., see Deochand, C. (2) 373–386

Agarwal, A.R., see Yu, R. (1) 133–148

Aharon-Peretz, J., see Malishkevich, A. (1) 249–260

Alcolea, D., see Carmona-Iragui, M. (1) 1–7

Alcolea, D., see Morenas-Rodríguez, E. (2) 539–546

Alegret, M., see Ibarria, M. (2) 559–566

Alemán-Gómez, Y., see Lacalle-Aurioles, M. (4) 1051–1064

Alexander, A.L., see Melah, K.E. (3) 873–886

Alexander, R.C., see Eketjäll, S. (4) 1109–1123

Alghamdi, A., see Vallortigara, J. (1) 101–110

Allali, G., see Wang, N. (3) 699–707

Andersen, B.B., see Hoffmann, K. (2) 443–453

Ando, Y., see Mishima, A. (1) 161–174

Andreassen, O.A., see Vijayaraghavan, S. (2) 567–576

Antenucci, M., see Siotto, M. (4) 1181–1189

Anthonissen, R., see Maes, A. (3) 741–749

Antoine, P., see Avondino, E. (1) 89–99

Antón-Aguirre, S., see Carmona-Iragui, M. (1) 1–7

Arai, H., see Yamashita, S. (2) 527–537

Arai, T., see Takahashi, S. (3) 751–758

Arcaro, M., see Oldoni, E. (2) 353–357

Ardekani, B.A., A. Convit and A.H. Bachman, Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression (3) 847–857

Aricò, M., see Gallucci, M. (4) 969–979

Arighi, A., see Oldoni, E. (2) 353–357

Arosio, B., see Oldoni, E. (2) 353–357

Arquizan, C., see Renard, D. (3) 759–764

Arrey, T.N., see Stockburger, C. (1) 201–215

Asada, T., see Takahashi, S. (3) 751–758

Ashby, E.L., J.S. Miners, P.G. Kehoe and S. Love, Effects of Hypertension and Anti-Hypertensive Treatment on Amy-loid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex (4) 1191–1203

Asthana, S., see Melah, K.E. (3) 873–886

Attems, J., see Vallortigara, J. (1) 101–110

Au, R., see Lebowitz, B.K. (1) 41–45

Auerbach, S., see Lebowitz, B.K. (1) 41–45

Auestad, B.H., see Vijayaraghavan, S. (2) 567–576

Avila, J., see Bolós, M. (1) 77–87

Avondino, E. and P. Antoine, Heterogeneity of Cognitive Anosognosia and its Variation with the Severity of Dementia in Patients with Alzheimer’s Disease (1) 89–99

Ayrignac, X., see Renard, D. (3) 759–764

Azakri, S., see Renard, D. (3) 759–764

Babić Leko, M., F. Boroveˇki, N. Dejanović, P.R. Hof and G. Šimić, Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer’s Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment (3) 765–778

Bachman, A.H., see Ardekani, B.A. (3) 847–857

Baeumlisberger, M., see Stockburger, C. (1) 201–215

Baiardi, S., S. Capellari, A. Ladogana, S. Strumia, M. Santangelo, M. Pocchiari and P. Parchi, Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings (2) 465–476

Bak, H.-r., see Lim, S. (1) 189–200

Balietti, M., C. Giuli, P. Fattoretti, P. Fabbietti, D. Postacchini and F. Conti, Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment (4) 957–962

Ballard, C.G., see Vallortigara, J. (1) 101–110

Bao, M., see Shi, S. (3) 859–871

Barbeau, E.J., see Pistono, A. (3) 687–698

Barkhof, F., see Rhodius-Meester, H.F.M. (1) 261–270

Bartolotti, N., L. Segura and O. Lazarov, Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer’s Disease Mice (2) 477–489

Bateman, R.J., see Chatterjee, P. (3) 887–894

Baumann, M., see Tholen, S. (3) 791–796

Bavinck, C., see Claus, J.J. (3) 797–806

Bayer, T.A., see Weissmann, R. (2) 397–409

Becker, J.T., see Ibarria, M. (2) 559–566

Becker, J.T., see Kuźma, E. (4) 1099–1108

Beiser, A., see Lebowitz, B.K. (1) 41–45

Belkacemi, A. and C. Ramassamy, Anthocyanins Protect SK-N-SH Cells Against Acrolein-Induced Toxicity by Preserving the Cellular Redox State (4) 981–998

Bendlin, B.B., see Melah, K.E. (3) 873–886

Benito-León, J., see Bermejo-Pareja, F. (3) 719–731

Benoit, S., see Langlois, R. (4) 1023–1033

Benussi, L., see Oldoni, E. (2) 353–357

Benzinger, T., see Chatterjee, P. (3) 887–894

Berge, G., see Vijayaraghavan, S. (2) 567–576

Bermejo-Pareja, F., I. Contador, R. Trincado, D. Lora, A. Sánchez-Ferro, A.J. Mitchell, E. Boycheva, A. Herrero, J. Hernández-Gallego, S. Llamas, A.V. Galende and J. Benito-León, Prognostic Significance of Mild Cognitive Impairment Subtypes for Dementia and Mortality: Data from the NEDICES Cohort (3) 719–731

Bettarini, F., see Malara, A. (4) 1217–1225

Beyer, N., see Hoffmann, K. (2) 443–453

Bharadwaj, P., see Porter, T. (3) 895–905

Binetti, G., see Oldoni, E. (2) 353–357

Bittner, D., see Kleinschmidt, M. (1) 111–126

Bjerregaard, E., see Hoffmann, K. (2) 443–453

Blennow, K., see Melah, K.E. (3) 873–886

Blesa, R., see Carmona-Iragui, M. (1) 1–7

Blesa, R., see Morenas-Rodríguez, E. (2) 539–546

Blumen, H.M., see Wang, N. (3) 699–707

Boada, M., see Ibarria, M. (2) 559–566

Boccardi, V., C. Ruggiero, A. Patriti and L. Marano, Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer’s Disease (4) 947–955

Bocti, C., see Bourgade, K. (4) 1227–1241

Bogstedt, A., see Eketjäll, S. (4) 1109–1123

Bolós, M., M. Llorens-Martín, J. Jurado-Arjona, F. Hernández, A. Rábano and J. Avila, Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo (1) 77–87

Bonní, S., see Koch, G. (2) 605–616

Boroveˇki, F., see Babić Leko, M. (3) 765–778

Bouly, S., see Renard, D. (3) 759–764

Bourgade, K., A. Le Page, C. Bocti, J.M. Witkowski, G. Dupuis, E.H. Frost and T. Fülöp Jr., Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model (4) 1227–1241

Bouter, Y., see Weissmann, R. (2) 397–409

Boycheva, E., see Bermejo-Pareja, F. (3) 719–731

Bozzali, M., see Koch, G. (2) 605–616

Bozzali, M., see Makovac, E. (2) 591–604

Brændgaard, H., see Hoffmann, K. (2) 443–453

Bratzke, L.C., see Melah, K.E. (3) 873–886

Bravo-Caraduje, N., see Quintana-Hernández, D.J. (1) 217–232

Brisswalter, J., see Sacco, G. (1) 19–25

Brown, B.M., see Chatterjee, P. (3) 887–894

Bruno, G., see Oldoni, E. (2) 353–357

Buckley, A.H., see Hardy, C.J.D. (2) 359–371

Bucossi, S., see Siotto, M. (4) 1181–1189

Bursey, D., see Oldoni, E. (2) 353–357

Buschke, H., see Gramunt, N. (4) 999–1010

Cacciari, C., see Spalletta, G. (3) 807–816

Cacioppo, J.T., see Dodich, A. (4) 1011–1022

Cadenas, E., see Deochand, C. (2) 373–386

Cadenas, E., see Yu, R. (1) 133–148

Caillaud, C., see Sacco, G. (1) 19–25

Caltagirone, C., see Koch, G. (2) 605–616

Caltagirone, C., see Makovac, E. (2) 591–604

Caltagirone, C., see Spalletta, G. (3) 807–816

Calvet, B., see Pistono, A. (3) 687–698

Camacho, V., see Carmona-Iragui, M. (1) 1–7

Cañabate, P., see Ibarria, M. (2) 559–566

Canessa, N., see Dodich, A. (4) 1011–1022

Cao, X., see Jin, H. (2) 501–516

Cao, Y., see Hisatsune, T. (1) 149–159

Capellari, S., see Baiardi, S. (2) 465–476

Cappa, S.F., see Dodich, A. (4) 1011–1022

Caprara, D., see Siotto, M. (4) 1181–1189

Carlsson, C.M., see Melah, K.E. (3) 873–886

Carmona-Iragui, M., A. Fernández-Arcos, D. Alcolea, F. Piazza, E. Morenas-Rodriguez, S. Antón-Aguirre, I. Sala, J. Clarimon, O. Dols-Icardo, V. Camacho, F. Sampedro, J. Munuera, F. Nuñez-Marin, A. Lleó, J. Fortea, B. Gómez-Ansón and R. Blesa, Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation (1) 1–7

Carmona-Iragui, M., see Morenas-Rodríguez, E. (2) 539–546

Case, M., see Hochstetler, H. (1) 271–282

Casini, A.R., see Spalletta, G. (3) 807–816

Castro, L., see Fernández, G. (3) 827–838

Cebers, G., see Eketjäll, S. (4) 1109–1123

Cerami, C., see Dodich, A. (4) 1011–1022

Ceravolo, F., see Malara, A. (4) 1217–1225

Cercignani, M., see Makovac, E. (2) 591–604

Cervera-Carles, L., see Morenas-Rodríguez, E. (2) 539–546

Cha, J., see Kim, H.J. (3) 709–718

Chakrabarti, M., A.J. McDonald, J.W. Reed, M.A. Moss, B.C. Das and S.K. Ray, Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer’s Disease (2) 335–352

Chang, Y.-L., Y.-S. Yen, T.-F. Chen, S.-H. Yan and W.-Y.I. Tseng, Clinical Dementia Rating Scale Detects White Matter Changes in Older Adults at Risk for Alzheimer’s Disease (2) 411–423

Charidimou, A., Cerebral Amyloid Angiopathy-Related Inflammation Biomarkers: Where are we Now? (1) 9–11

Charif, M., see Renard, D. (3) 759–764

Chatterjee, P., W.L.F. Lim, G. Shui, V.B. Gupta, I. James, A.M. Fagan, C. Xiong, H.R. Sohrabi, K. Taddei, B.M. Brown, T. Benzinger, C. Masters, S.G. Snowden, M.R. Wenk, R.J. Bateman, J.C. Morris and R.N. Martins, Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study (3) 887–894

Chaves, P.H.M., see Kuźma, E. (4) 1099–1108

Chen, L., see Jin, H. (2) 501–516

Chen, T., see Jin, H. (2) 501–516

Chen, T.-F., see Chang, Y.-L. (2) 411–423

Chettle, D.R., see Mohseni, H.K. (4) 913–926

Chiang, H.-S., see Mudar, R.A. (2) 577–590

Chiapponi, C., see Spalletta, G. (3) 807–816

Chiu, P.-Y., see Li, H.-H. (4) 1083–1098

Chmielewski, S., see Tholen, S. (3) 791–796

Choe, Y.S., see Kim, H.J. (3) 709–718

Choi, J.G., see Lim, S. (1) 189–200

Clarimon, J., see Carmona-Iragui, M. (1) 1–7

Clarimón, J., see Morenas-Rodríguez, E. (2) 539–546

Claus, J.J., S.S. Staekenborg, J.J. Roorda, M. Stevens, D. Herderschee, W. van Maarschalkerweerd, L. Schuurmans, C.E.M. Tielkes, P. Koster, C. Bavinck and P. Scheltens, Low Prevalence of Mixed Dementia in a Cohort of 2,000 Elderly Patients in a Memory Clinic Setting (3) 797–806

Comijs, H., see Kuźma, E. (4) 1099–1108

Confaloni, A., see Oldoni, E. (2) 353–357

Contador, I., see Bermejo-Pareja, F. (3) 719–731

Conti, F., see Balietti, M. (4) 957–962

Convit, A., see Ardekani, B.A. (3) 847–857

Cotman, C.W., see Hoffmann, K. (2) 443–453

Cravello, L., see Spalletta, G. (3) 807–816

Crespi, C., see Dodich, A. (4) 1011–1022

Crutch, S.J., see Hardy, C.J.D. (2) 359–371

Cruz-Orduña, I., see Lacalle-Aurioles, M. (4) 1051–1064

Cui, Z., see Gao, L. (1) 13–17

Cutter, G.R., see Kennedy, R.E. (4) 1205–1215

Darby, D., see Takahashi, S. (3) 751–758

Darreh-Shori, T., see Vijayaraghavan, S. (2) 567–576

Das, B.C., see Chakrabarti, M. (2) 335–352

David, R., see Sacco, G. (1) 19–25

De Biase, G.A., see Malara, A. (4) 1217–1225

de Jager, C.A., see Oulhaj, A. (2) 547–557

de la Monte, S.M. see Deochand, C. (2) 373–386

de la Monte, S.M., see Yu, R. (1) 133–148

Deeg, D.J.H., see Kuźma, E. (4) 1099–1108

Degenhardt, E., see Hochstetler, H. (1) 271–282

Dejanović, N., see Babić Leko, M. (3) 765–778

del Carmen Pérez-Vieitez, M., see Quintana-Hernández, D.J. (1) 217–232

Demuth, H.-U., see Kleinschmidt, M. (1) 111–126

Deng, F., see Zhu, M. (4) 1149–1162

Deochand, C., M. Tong, A.R. Agarwal, E. Cadenas and S.M. de la Monte, Tobacco Smoke Exposure Impairs Brain Insulin/IGF Signaling: Potential Co-Factor Role in Neurodegeneration (2) 373–386

Deochand, C., see Yu, R. (1) 133–148

Dermody, N., M. Hornberger, O. Piguet, J.R. Hodges and M. Irish, Prospective Memory Impairments in Alzheimer’s Disease and Behavioral Variant Frontotemporal Dementia: Clinical and Neural Correlates (2) 425–441

Desco, M., see Lacalle-Aurioles, M. (4) 1051–1064

Destiche, D.J., see Melah, K.E. (3) 873–886

Di Cello, S., see Malara, A. (4) 1217–1225

Di Lorenzo, F., see Koch, G. (2) 605–616

Diego, S., see Ibarria, M. (2) 559–566

Dodich, A., C. Cerami, C. Crespi, N. Canessa, G. Lettieri, S. Iannaccone, A. Marcone, S.F. Cappa and J.T. Cacioppo, Differential Impairment of Cognitive and Affective Mentalizing Abilities in Neurodegenerative Dementias: Evidence from Behavioral Variant of Frontotemporal Dementia, Alzheimer’s Disease, and Mild Cognitive Impairment (4) 1011–1022

Dols-Icardo, O., see Carmona-Iragui, M. (1) 1–7

Dols-Icardo, O., see Morenas-Rodríguez, E. (2) 539–546

Dostie, V., see Langlois, R. (4) 1023–1033

Dowling, N.M., see Melah, K.E. (3) 873–886

Downey, L.E., see Hardy, C.J.D. (2) 359–371

Dupuis, G., see Bourgade, K. (4) 1227–1241

Dziedzic, T., J. Pera, A. Klimkowicz-Mrowiec, B. Mroczko and A. Slowik, Biochemical and Radiological Markers of Alzheimer’s Disease Progression (3) 623–644

Eichler, T., see Michalowsky, B. (1) 47–59

Eketjäll, S., J. Janson, K. Kaspersson, A. Bogstedt, F. Jeppsson, J. Fälting, S.B. Haeberlein, A.R. Kugler, R.C. Alexander and G. Cebers, AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics (4) 1109–1123

Endres, K., see Schuck, F. (3) 817–826

Eroh, J., see Mudar, R.A. (2) 577–590

Eustache, P., F. Nemmi, L. Saint-Aubert, J. Pariente and P. Péran, Multimodal Magnetic Resonance Imaging in Alzheimer’s Disease Patients at Prodromal Stage (4) 1035–1050

Ezra, A., I. Rabinovich-Nikitin, P. Rabinovich-Toidman and B. Solomon, Multifunctional Effect of Human Serum Albumin Reduces Alzheimer’s Disease Related Pathologies in the 3xTg Mouse Model (1) 175–188

Fabbietti, P., see Balietti, M. (4) 957–962

Fadda, L., see Marra, C. (1) 61–70

Fagan, A.M., see Chatterjee, P. (3) 887–894

Fälting, J., see Eketjäll, S. (4) 1109–1123

Fattoretti, P., see Balietti, M. (4) 957–962

Fauria, K., see Gramunt, N. (4) 999–1010

Fellgiebel, A., see Schuck, F. (3) 817–826

Fenoglio, C., see Oldoni, E. (2) 353–357

Fernandez del Olmo, M., see Koch, G. (2) 605–616

Fernández, G., F. Manes, L.E. Politi, D. Orozco, M. Schumacher, L. Castro, O. Agamennoni and N.P. Rotstein, Patients with Mild Alzheimer’s Disease Fail When Using Their Working Memory: Evidence from the Eye Tracking Technique (3) 827–838

Fernández-Arcos, A., see Carmona-Iragui, M. (1) 1–7

Fischer, C.E., W. Qian, T.A. Schweizer, C.P. Millikin, Z. Ismail, E.E. Smith, L.M. Lix, P. Shelton and D.G. Munoz, Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer’s Disease (1) 283–295

Flessa, S., see Michalowsky, B. (1) 47–59

Förstl, H., see Tholen, S. (3) 791–796

Fortea, J., see Carmona-Iragui, M. (1) 1–7

Fortea, J., see Morenas-Rodríguez, E. (2) 539–546

Fourcade, G., see Renard, D. (3) 759–764

Francis, P.T., see Vallortigara, J. (1) 101–110

Fratangeli, C., see Spalletta, G. (3) 807–816

Frederiksen, K.S., see Hoffmann, K. (2) 443–453

Friedland, K., see Stockburger, C. (1) 201–215

Frost, E.H., see Bourgade, K. (4) 1227–1241

Fujita, K., see Yasue, I. (3) 733–740

Fujiwara, H., see Yamashita, S. (2) 527–537

Fülöp Jr., T., see Bourgade, K. (4) 1227–1241

Fumagalli, G.G., see Oldoni, E. (2) 353–357

Furukawa, K., see Yamashita, S. (2) 527–537

Gabelle, A., see Renard, D. (3) 759–764

Gainotti, G., see Marra, C. (1) 61–70

Galende, A.V., see Bermejo-Pareja, F. (3) 719–731

Galimberti, D., see Oldoni, E. (2) 353–357

Gallucci, M., P. Spagnolo, M. Aricò and E. Grossi, Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer’s Disease: Date Mining from the TREDEM Registry (4) 969–979

Gao, L., Z. Cui, L. Shen and H.-F. Ji, Shared Genetic Etiology between Type 2 Diabetes and Alzheimer’s Disease Identified by Bioinformatics Analysis (1) 13–17

Gao, Q., see Lim, S.L. (1) 27–40

Gardener, S.L., S.R. Rainey-Smith and R.N. Martins, Diet and Inflammation in Alzheimer’s Disease and Related Chronic Diseases: A Review (2) 301–334

Garo, M., see Malara, A. (4) 1217–1225

Geng, S., see Zhu, M. (4) 1149–1162

Gergelyffy, R.G., see Hoffmann, K. (2) 443–453

Ghidoni, R., see Oldoni, E. (2) 353–357

Gianni, W., see Spalletta, G. (3) 807–816

Gispert, J.D., see Gramunt, N. (4) 999–1010

Giuli, C., see Balietti, M. (4) 957–962

Giulietti, G., see Makovac, E. (2) 591–604

Glabe, C., see Hatami, A. (2) 517–525

Gleason, C.E., see Melah, K.E. (3) 873–886

Goldstein, F.C., see Steenland, K. (1) 71–76

Gómez-Ansón, B., see Carmona-Iragui, M. (1) 1–7

Gong, L., see Lim, S.L. (1) 27–40

Göttlich, C., see Kleinschmidt, M. (1) 111–126

Gottrup, H., see Hoffmann, K. (2) 443–453

Gozes, I., see Malishkevich, A. (1) 249–260

Gramunt, N., G. Sánchez-Benavides, H. Buschke, R.B. Lipton, X. Masramon, J.D. Gispert, J. Peña-Casanova, K. Fauria and J.L. Molinuevo, Psychometric Properties of the Memory Binding Test: Test-Retest Reliability and Convergent Validity (4) 999–1010

Grande, G., see Oldoni, E. (2) 353–357

Grimmer, T., see Tholen, S. (3) 791–796

Grossi, E., see Gallucci, M. (4) 969–979

Groth, D., see Porter, T. (3) 895–905

Gu, Q., see Luo, X. (4) 1137–1148

Guan, X., see Luo, X. (4) 1137–1148

Guitart, M., see Ibarria, M. (2) 559–566

Gupta, V.B., see Chatterjee, P. (3) 887–894

Guzmán-De-Villoria, J.A., see Lacalle-Aurioles, M. (4) 1051–1064

Haeberlein, S.B., see Eketjäll, S. (4) 1109–1123

Han, C.E., see Jung, N.-Y. (4) 1125–1135

Hardy, C.J.D., A.H. Buckley, L.E. Downey, M. Lehmann, V.C. Zimmerer, R.A. Varley, S.J. Crutch, J.D. Rohrer, E.K. Warrington and J.D. Warren, The Language Profile of Behavioral Variant Frontotemporal Dementia (2) 359–371

Hart Jr., J., see Mudar, R.A. (2) 577–590

Hashimoto, M., see Yamashita, S. (2) 527–537

Hasselbalch, S.G., see Hoffmann, K. (2) 443–453

Hatami, A., S. Monjazeb and C. Glabe, The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils (2) 517–525

Hattori, S., see Takahashi, S. (3) 751–758

Hayashi, S., see Nagata, T. (3) 839–845

Heemann, U., see Tholen, S. (3) 791–796

Henley, D.B., see Hochstetler, H. (1) 271–282

Henley, W.E., see Kuźma, E. (4) 1099–1108

Herderschee, D., see Claus, J.J. (3) 797–806

Hernández, F., see Bolós, M. (1) 77–87

Hernández, I., see Ibarria, M. (2) 559–566

Hernández, J., see Ibarria, M. (2) 559–566

Hernández-Gallego, J., see Bermejo-Pareja, F. (3) 719–731

Herrero, A., see Bermejo-Pareja, F. (3) 719–731

Hertel, J., see Michalowsky, B. (1) 47–59

Hirtz, C., see Renard, D. (3) 759–764

Hisatsune, T., J. Kaneko, H. Kurashige, Y. Cao, H. Satsu, M. Totsuka, Y. Katakura, E. Imabayashi and H. Matsuda, Effect of Anserine/Carnosine Supplementation on Verbal Episodic Memory in Elderly People (1) 149–159

Ho, J., see Nation, D.A. (3) 779–789

Hochstetler, H., P.T. Trzepacz, S. Wang, P. Yu, M. Case, D.B. Henley, E. Degenhardt, J.-M. Leoutsakos and C.G. Lyketsos for the Alzheimer’s Disease Neuroimaging Initiative, Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline (1) 271–282

Hodges, J.R., see Dermody, N. (2) 425–441

Hof, P.R., see Babić Leko, M. (3) 765–778

Hoffmann, K., N.A. Sobol, K.S. Frederiksen, N. Beyer, A. Vogel, K. Vestergaard, H. Brændgaard, H. Gottrup, A. Lolk, L. Wermuth, S. Jacobsen, L.P. Laugesen, R.G. Gergelyffy, P. Høgh, E. Bjerregaard, B.B. Andersen, V. Siersma, P. Johannsen, C.W. Cotman, G. Waldemar and S.G. Hasselbalch, Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial (2) 443–453

Hoffmann, W., see Michalowsky, B. (1) 47–59

Høgh, P., see Hoffmann, K. (2) 443–453

Honkura, K., see Sugiyama, K. (2) 491–500

Hornberger, M., see Dermody, N. (2) 425–441

Hort, J., see Ni, L. (4) 1243–1254

Hortobágyi, T., see Vallortigara, J. (1) 101–110

Hoscheidt, S.M., see Melah, K.E. (3) 873–886

Howlett, D., see Vallortigara, J. (1) 101–110

Hu, X., see Huang, F. (3) 659–667

Huang, C., see Zhu, M. (4) 1149–1162

Huang, C.-N., see Li, H.-H. (4) 1083–1098

Huang, F., Y. Shang, Y. Luo, P. Wu, X. Huang, X. Tan, X. Lu, L. Zhen and X. Hu, Lower Prevalence of Alzheimer’s Disease among Tibetans: Association with Religious and Genetic Factors (3) 659–667

Huang, P., see Luo, X. (4) 1137–1148

Huang, W.-N., see Li, H.-H. (4) 1083–1098

Huang, X., see Huang, F. (3) 659–667

Hüttenrauch, M., see Weissmann, R. (2) 397–409

Iannaccone, S., see Dodich, A. (4) 1011–1022

Ibáñez-Fernández, I.J., see Quintana-Hernández, D.J. (1) 217–232

Ibarria, M., M. Alegret, S. Valero, A. Morera, M. Guitart, P. Cañabate, M. Moreno, S. Lara, S. Diego, J. Hernández, N. Tantinyá, M. Vera, I. Hernández, J.T. Becker, A. Ruíz, M. Boada and L. Tárraga for the Fundació ACE Alzheimer Research Center and Memory Clinic, Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer’s Disease (2) 559–566

Imabayashi, E., see Hisatsune, T. (1) 149–159

Iorio, M., see Spalletta, G. (3) 807–816

Irish, M., see Dermody, N. (2) 425–441

Ismail, Z., see Fischer, C.E. (1) 283–295

Ito, K., see Mishima, A. (1) 161–174

Iwata, N., see Yasue, I. (3) 733–740

Jacobsen, S., see Hoffmann, K. (2) 443–453

Jagust, W.J., see Jung, N.-Y. (4) 1125–1135

James, I., see Chatterjee, P. (3) 887–894

Janson, J., see Eketjäll, S. (4) 1109–1123

Jeppsson, F., see Eketjäll, S. (4) 1109–1123

Jernerén, F., see Oulhaj, A. (2) 547–557

Ji, H.-F., see Gao, L. (1) 13–17

Jia, Y., see Luo, X. (4) 1137–1148

Jiang, Y., see Zhu, M. (4) 1149–1162

Jin, H., T. Chen, G. Li, C. Wang, B. Zhang, X. Cao, S. Sha, Q. Wan and L. Chen, Dose-Dependent Neuroprotection and Neurotoxicity of Simvastatin through Reduction of Farnesyl Pyrophosphate in Mice Treated with Intracerebroventricular Injection of Aβ1-42 (2) 501–516

Johannsen, P., see Hoffmann, K. (2) 443–453

Johnson, M., see Vallortigara, J. (1) 101–110

Johnson, S.C., see Melah, K.E. (3) 873–886

Joubert, S., see Langlois, R. (4) 1023–1033

Jucla, M., see Pistono, A. (3) 687–698

Jung, N.-Y., C.E. Han, H.J. Kim, S.W. Yoo, H.-J. Kim, E.-J. Kim, D.L. Na, S.N. Lockhart, W.J. Jagust, J.-K. Seong and S.W. Seo, Tract-Specific Correlates of Neuropsychological Deficits in Patients with Subcortical Vascular Cognitive Impairment (4) 1125–1135

Jung, N.-Y., see Kim, H.J. (3) 709–718

Jurado-Arjona, J., see Bolós, M. (1) 77–87

Kacprowski, T., see Weissmann, R. (2) 397–409

Kaiho, Y., see Sugiyama, K. (2) 491–500

Kaneko, J., see Hisatsune, T. (1) 149–159

Karas, M., see Stockburger, C. (1) 201–215

Kaspersson, K., see Eketjäll, S. (4) 1109–1123

Katakura, Y., see Hisatsune, T. (1) 149–159

Kato, T., see Mishima, A. (1) 161–174

Kauwe, J.S., see Oldoni, E. (2) 353–357

Kawai, H., see Mishima, A. (1) 161–174

Kehoe, P.G., see Ashby, E.L. (4) 1191–1203

Kennedy, R.E., G.R. Cutter, G. Wang and L.S. Schneider, Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials (4) 1205–1215

Kesavadas, C., see Wang, N. (3) 699–707

Kestenbaum, B.R., see Kuźma, E. (4) 1099–1108

Kiko, T., see Yamashita, S. (2) 527–537

Kikuchi, N., see Takahashi, S. (3) 751–758

Kim, E.-J., see Jung, N.-Y. (4) 1125–1135

Kim, H.G., see Lim, S. (1) 189–200

Kim, H.J., J. Cha, J.-M. Lee, J.S. Shin, N.-Y. Jung, Y.J. Kim, Y.S. Choe, K.H. Lee, S.T. Kim, J.S. Kim, J.H. Lee, D.L. Na and S.W. Seo, Distinctive Resting State Network Disruptions Among Alzheimer’s Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients (3) 709–718

Kim, H.J., see Jung, N.-Y. (4) 1125–1135

Kim, H.-J., see Jung, N.-Y. (4) 1125–1135

Kim, J.S., see Kim, H.J. (3) 709–718

Kim, S.T., see Kim, H.J. (3) 709–718

Kim, S.Y., see Lim, S. (1) 189–200

Kim, Y.J., see Kim, H.J. (3) 709–718

Kinoshita, M., see Yamashita, S. (2) 527–537

Kishi, T., see Yasue, I. (3) 733–740

Klarin, I., see Wimo, A. (2) 387–396

Kleinschmidt, M., R. Schoenfeld, C. Göttlich, D. Bittner, J.E. Metzner, B. Leplow and H.-U. Demuth, Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology (1) 111–126

Klimkowicz-Mrowiec, A., see Dziedzic, T. (3) 623–644

Koch, G., F. Di Lorenzo, M. Fernandez del Olmo, S. Bonní, V. Ponzo, C. Caltagirone, M. Bozzali and A. Martorana, Reversal of LTP-Like Cortical Plasticity in Alzheimer’s Disease Patients with Tau-Related Faster Clinical Progression (2) 605–616

Koikkalainen, J., see Rhodius-Meester, H.F.M. (1) 261–270

Kokjohn, T.A., see Roher, A.E. (3) 645–658

Köpke, B., see Pistono, A. (3) 687–698

Koster, P., see Claus, J.J. (3) 797–806

Kraut, M.A., see Mudar, R.A. (2) 577–590

Krotow, A., see Yu, R. (1) 133–148

Kugler, A.R., see Eketjäll, S. (4) 1109–1123

Kuller, L.H., see Kuźma, E. (4) 1099–1108

Kung, F., see Mudar, R.A. (2) 577–590

Kurashige, H., see Hisatsune, T. (1) 149–159

Kuss, A.W., see Weissmann, R. (2) 397–409

Kuźma, E., M. Soni, T.J. Littlejohns, J.M. Ranson, N.M. van Schoor, D.J.H. Deeg, H. Comijs, P.H.M. Chaves, B.R. Kestenbaum, L.H. Kuller, O.L. Lopez, J.T. Becker, K.M. Langa, W.E. Henley, I.A. Lang, O.C. Ukoumunne and D.J. Llewellyn, Vitamin D and Memory Decline: Two Population-Based Prospective Studies (4) 1099–1108

Lacalle-Aurioles, M., F.J. Navas-Sánchez, Y. Alemán-Gómez, J. Olazarán, J.A. Guzmán-De-Villoria, I. Cruz-Orduña, J.M. Mateos-Pérez and M. Desco, The Disconnection Hypothesis in Alzheimer’s Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging (4) 1051–1064

Lacidogna, G., see Marra, C. (1) 61–70

Ladogana, A., see Baiardi, S. (2) 465–476

Lai, T.-J., see Li, H.-H. (4) 1083–1098

Lang, I.A., see Kuźma, E. (4) 1099–1108

Langa, K.M., see Kuźma, E. (4) 1099–1108

Langlois, R., S. Joubert, S. Benoit, V. Dostie and I. Rouleau, Memory for Public Events in Mild Cognitive Impairment and Alzheimer’s Disease: The Importance of Rehearsal (4) 1023–1033

Lara, S., see Ibarria, M. (2) 559–566

Laugesen, L.P., see Hoffmann, K. (2) 443–453

Laws, S.M., see Porter, T. (3) 895–905

Lazarov, O., see Bartolotti, N. (2) 477–489

Le Floch, A., see Renard, D. (3) 759–764

Le Page, A., see Bourgade, K. (4) 1227–1241

Le, W., see Qiu, H. (3) 669–685

Leão, R., see Yu, R. (1) 133–148

Lebowitz, B.K., C. Weinstein, A. Beiser, S. Seshadri, P.A. Wolf, S. Auerbach and R. Au, Lifelong Reading Disorder and Mild Cognitive Impairment: Implications for Diagnosis (1) 41–45

Lee, J.H., see Kim, H.J. (3) 709–718

Lee, J.-M., see Kim, H.J. (3) 709–718

Lee, K.H., see Kim, H.J. (3) 709–718

Lee, W., see Lim, S. (1) 189–200

Lehmann, M., see Hardy, C.J.D. (2) 359–371

Lehmann, S., see Renard, D. (3) 759–764

Lemesle, B., see Pistono, A. (3) 687–698

Lemstra, A.W., see Rhodius-Meester, H.F.M. (1) 261–270

Leoutsakos, J.-M., see Hochstetler, H. (1) 271–282

Leplow, B., see Kleinschmidt, M. (1) 111–126

Lettieri, G., see Dodich, A. (4) 1011–1022

Levey, A., see Steenland, K. (1) 71–76

Li, G., see Jin, H. (2) 501–516

Li, H., see Zhang, T. (2) 455–463

Li, H.-H., S.-L. Lin, C.-N. Huang, F.-J. Lu, P.-Y. Chiu, W.-N. Huang, T.-J. Lai and C.-L. Lin, miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling (4) 1083–1098

Li, M., see Ni, L. (4) 1243–1254

Li, S., see Qiu, H. (3) 669–685

Li, X., see Zhang, T. (2) 455–463

Li, X., see Zhu, M. (4) 1149–1162

Liang, D., see Shi, S. (3) 859–871

Liang, Z., see Zhu, M. (4) 1149–1162

Lim, M.L., see Lim, S.L. (1) 27–40

Lim, S., J.G. Choi, M. Moon, H.G. Kim, W. Lee, H.-r. Bak, H. Sung, C.H. Park, S.Y. Kim and M.S. Oh, An Optimized Combination of Ginger and Peony Root Effectively Inhibits Amyloid-β Accumulation and Amyloid-β-Mediated Pathology in AβPP/PS1 Double-Transgenic Mice (1) 189–200

Lim, S.L., Q. Gao, M.S.Z. Nyunt, L. Gong, J.B. Lunaria, M.L. Lim, A. Ling, C. Su-Ping Lam, A.M. Richards, L.H. Ling and T.P. Ng, Vascular Health Indices and Cognitive Domain Function: Singapore Longitudinal Ageing Studies (1) 27–40

Lim, W.L.F., see Chatterjee, P. (3) 887–894

Lim, Y.Y., see Santos, C.Y. (1) 127–131

Lin, C.-L., see Li, H.-H. (4) 1083–1098

Lin, S.-L., see Li, H.-H. (4) 1083–1098

Ling, A., see Lim, S.L. (1) 27–40

Ling, L.H., see Lim, S.L. (1) 27–40

Lipton, R.B., see Gramunt, N. (4) 999–1010

Littlejohns, T.J., see Kuźma, E. (4) 1099–1108

Liu, G., see Wang, S. (1) 233–248

Liu, H., see Qiu, H. (3) 669–685

Liu, R., see Ni, L. (4) 1243–1254

Lix, L.M., see Fischer, C.E. (1) 283–295

Llamas, S., see Bermejo-Pareja, F. (3) 719–731

Lleó, A., see Carmona-Iragui, M. (1) 1–7

Lleó, A., see Morenas-Rodríguez, E. (2) 539–546

Llewellyn, D.J., see Kuźma, E. (4) 1099–1108

Llorens-Martín, M., see Bolós, M. (1) 77–87

Lockhart, S.N., see Jung, N.-Y. (4) 1125–1135

Lolk, A., see Hoffmann, K. (2) 443–453

Lopez, O.L., see Kuźma, E. (4) 1099–1108

Lora, D., see Bermejo-Pareja, F. (3) 719–731

Lötjönen, J., see Rhodius-Meester, H.F.M. (1) 261–270

Love, S., see Ashby, E.L. (4) 1191–1203

Lu, F.-J., see Li, H.-H. (4) 1083–1098

Lu, X., see Huang, F. (3) 659–667

Lunaria, J.B., see Lim, S.L. (1) 27–40

Luo, X., T. Qiu, X. Xu, P. Huang, Q. Gu, Z. Shen, X. Yu, Y. Jia, X. Guan, R. Song, M. Zhang and for the Alzheimer’s Disease Neuroimaging Initiative, Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE ɛ4 Carriers: A Preliminary Study (4) 1137–1148

Luo, Y., see Huang, F. (3) 659–667

Lyketsos, C.G. see Hochstetler, H. (1) 271–282

Ma, X., see Zhu, M. (4) 1149–1162

Maarouf, C.L., see Roher, A.E. (3) 645–658

Machan, J.T., see Santos, C.Y. (1) 127–131

Maes, A., R. Anthonissen, S. Wambacq, K. Simons and L. Verschaeve, The Cytome Assay as a Tool to Investigate the Possible Association Between Exposure to Extremely Low Frequency Magnetic Fields and an Increased Risk for Alzheimer’s Disease (3) 741–749

Maguire, M.J., see Mudar, R.A. (2) 577–590

Makovac, E., L. Serra, B. Spanò, G. Giulietti, M. Torso, M. Cercignani, C. Caltagirone and M. Bozzali, Different Patterns of Correlation between Grey and White Matter Integrity Account for Behavioral and Psychological Symptoms in Alzheimer’s Disease (2) 591–604

Malara, A., G.A. De Biase, F. Bettarini, F. Ceravolo, S. Di Cello, M. Garo, F. Praino, V. Settembrini, G. Sgrò, F. Spadea and V. Rispoli, Pain Assessment in Elderly with Behavioral and Psychological Symptoms of Dementia (4) 1217–1225

Malishkevich, A., G.A. Marshall, A.P. Schultz, R.A. Sperling, J. Aharon-Peretz and I. Gozes, Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer’s Disease Biomarkers (1) 249–260

Manes, F., see Fernández, G. (3) 827–838

Marano, L., see Boccardi, V. (4) 947–955

Marcone, A., see Dodich, A. (4) 1011–1022

Marelli, C., see Renard, D. (3) 759–764

Mari, D., see Oldoni, E. (2) 353–357

Mariani, C., see Oldoni, E. (2) 353–357

Mariani, S., see Siotto, M. (4) 1181–1189

Marra, C., G. Gainotti, L. Fadda, R. Perri, G. Lacidogna, E. Scaricamazza, C. Piccininni and D. Quaranta, Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer’s Disease: The Episodic Memory Score (EMS) (1) 61–70

Marshall, G.A., see Malishkevich, A. (1) 249–260

Martins, R.N., see Chatterjee, P. (3) 887–894

Martins, R.N., see Gardener, S.L. (2) 301–334

Martins, R.N., see Porter, T. (3) 895–905

Martorana, A., see Koch, G. (2) 605–616

Maruff, P., see Santos, C.Y. (1) 127–131

Masramon, X., see Gramunt, N. (4) 999–1010

Masters, C., see Chatterjee, P. (3) 887–894

Mateos-Pérez, J.M., see Lacalle-Aurioles, M. (4) 1051–1064

Matsuda, H., see Hisatsune, T. (1) 149–159

Matsunaga, S., see Yasue, I. (3) 733–740

Mattila, J., see Rhodius-Meester, H.F.M. (1) 261–270

McDonald, A.J., see Chakrabarti, M. (2) 335–352

Melah, K.E., S. Yuan-Fu Lu, S.M. Hoscheidt, A.L. Alexander, N. Adluru, D.J. Destiche, C.M. Carlsson, H. Zetterberg, K. Blennow, O.C. Okonkwo, C.E. Gleason, N.M. Dowling, L.C. Bratzke, H.A. Rowley, M.A. Sager, S. Asthana, S.C. Johnson and B.B. Bendlin, Cerebrospinal Fluid Markers of Alzheimer’s Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer’s Disease (3) 873–886

Metzner, J.E., see Kleinschmidt, M. (1) 111–126

MG Cioffi, S., see Oldoni, E. (2) 353–357

Miano, D., see Stockburger, C. (1) 201–215

Michalowsky, B., J.R. Thyrian, T. Eichler, J. Hertel, D. Wucherer, S. Flessa and W. Hoffmann, Economic Analysis of Formal Care, Informal Care, and Productivity Losses in Primary Care Patients who Screened Positive for Dementia in Germany (1) 47–59

Mihashi, Y., see Nagata, T. (3) 839–845

Millikin, C.P., see Fischer, C.E. (1) 283–295

Mimura, M., see Nagata, T. (3) 839–845

Miners, J.S., see Ashby, E.L. (4) 1191–1203

Miró-Barrachina, M.T., see Quintana-Hernández, D.J. (1) 217–232

Mishima, A., T. Nihashi, Y. Ando, H. Kawai, T. Kato, K. Ito and T. Terasawa, Biomarkers Differentiating Dementia with Lewy Bodies from Other Dementias: A Meta-Analysis (1) 161–174

Mitchell, A.J., see Bermejo-Pareja, F. (3) 719–731

Miyazawa, T., see Yamashita, S. (2) 527–537

Mizukami, K., see Takahashi, S. (3) 751–758

Mohseni, H.K. and D.R. Chettle, A History of In Vivo Neutron Activation Analysis in Measurement of Aluminum in Human Subjects (4) 913–926

Molinario, R., see Siotto, M. (4) 1181–1189

Molinuevo, J.L., see Gramunt, N. (4) 999–1010

Monjazeb, S., see Hatami, A. (2) 517–525

Moon, M., see Lim, S. (1) 189–200

Morales-Casanova, D., see Quintana-Hernández, D.J. (1) 217–232

Morenas-Rodríguez, E., L. Cervera-Carles, E. Vilaplana, D. Alcolea, M. Carmona-Iragui, O. Dols-Icardo, R. Ribosa-Nogué, L. Muñoz-Llahuna, I. Sala, M.B. Sánchez-Saudinós, R. Blesa, J. Clarimón, J. Fortea and A. Lleó, Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias (2) 539–546

Morenas-Rodriguez, E., see Carmona-Iragui, M. (1) 1–7

Moreno, M., see Ibarria, M. (2) 559–566

Morera, A., see Ibarria, M. (2) 559–566

Morris, J.C., see Chatterjee, P. (3) 887–894

Moss, M.A., see Chakrabarti, M. (2) 335–352

Mroczko, B., see Dziedzic, T. (3) 623–644

Mudar, R.A., H.-S. Chiang, J. Eroh, L.T. Nguyen, M.J. Maguire, J.S. Spence, F. Kung, M.A. Kraut and J. Hart Jr., The Effects of Amnestic Mild Cognitive Impairment on Go/NoGo Semantic Categorization Task Performance and Event-Related Potentials (2) 577–590

Müller, W.E., see Stockburger, C. (1) 201–215

Munoz, D.G., see Fischer, C.E. (1) 283–295

Muñoz-Llahuna, L., see Morenas-Rodríguez, E. (2) 539–546

Munuera, J., see Carmona-Iragui, M. (1) 1–7

Na, D.L., see Jung, N.-Y. (4) 1125–1135

Na, D.L., see Kim, H.J. (3) 709–718

Nacmias, B., see Oldoni, E. (2) 353–357

Nagata, T., S. Shinagawa, S. Nakajima, E. Plitman, Y. Mihashi, S. Hayashi, M. Mimura and K. Nakayama, Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer’s Disease: Analysis of the CATIE-AD Study (3) 839–845

Nakagawa, K., see Yamashita, S. (2) 527–537

Nakajima, S., see Nagata, T. (3) 839–845

Nakayama, K., see Nagata, T. (3) 839–845

Nation, D.A., J. Ho, B. Yew and for the Alzheimer’s Disease Neuroimaging Initiative, Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention (3) 779–789

Navas-Sánchez, F.J., see Lacalle-Aurioles, M. (4) 1051–1064

Nedelska, Z., see Ni, L. (4) 1243–1254

Nemmi, F., see Eustache, P. (4) 1035–1050

Ng, T.P., see Lim, S.L. (1) 27–40

Nguyen, L.T., see Mudar, R.A. (2) 577–590

Ni, L., R. Liu, Z. Yin, H. Zhao, Z. Nedelska, J. Hort, F. Zhou, W. Wu, X. Zhang, M. Li, H. Yu, B. Zhu, Y. Xu and B. Zhang, Aberrant Spontaneous Brain Activity in Patients with Mild Cognitive Impairment and Concomitant Lacunar Infarction: A Resting-State Functional MRI Study (4) 1243–1254

Nihashi, T., see Mishima, A. (1) 161–174

Noone, M.L., see Wang, N. (3) 699–707

Nordberg, G., see Wimo, A. (2) 387–396

Nuñez-Marin, F., see Carmona-Iragui, M. (1) 1–7

Nyunt, M.S.Z., see Lim, S.L. (1) 27–40

O’Brien, J.T., see Vallortigara, J. (1) 101–110

Ogawa, R., see Takahashi, S. (3) 751–758

Oh, M.S., see Lim, S. (1) 189–200

Okonkwo, O.C., see Melah, K.E. (3) 873–886

Olazarán, J., see Lacalle-Aurioles, M. (4) 1051–1064

Oldoni, E., G.G. Fumagalli, M. Serpente, C. Fenoglio, M. Scarioni, A. Arighi, G. Bruno, G. Talarico, A. Confaloni, P. Piscopo, B. Nacmias, S. Sorbi, I. Rainero, E. Rubino, L. Pinessi, G. Binetti, R. Ghidoni, L. Benussi, G. Grande, B. Arosio, D. Bursey, J.S. Kauwe, S. MG Cioffi, M. Arcaro, D. Mari, C. Mariani, E. Scarpini and D. Galimberti, PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population (2) 353–357

Orfei, M.D., see Spalletta, G. (3) 807–816

Orozco, D., see Fernández, G. (3) 827–838

Oulhaj, A., F. Jernerén, H. Refsum, A.D. Smith and C.A. de Jager, Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment (2) 547–557

Pallas, T., see Stockburger, C. (1) 201–215

Parchi, P., see Baiardi, S. (2) 465–476

Pariente, J., see Eustache, P. (4) 1035–1050

Pariente, J., see Pistono, A. (3) 687–698

Park, C.H., see Lim, S. (1) 189–200

Pasqualetti, P., see Siotto, M. (4) 1181–1189

Patriti, A., see Boccardi, V. (4) 947–955

Paxman, A., see Porter, T. (3) 895–905

Peña-Casanova, J., see Gramunt, N. (4) 999–1010

Pera, J., see Dziedzic, T. (3) 623–644

Péran, P., see Eustache, P. (4) 1035–1050

Perri, R., see Marra, C. (1) 61–70

Phillips, P., see Wang, S. (1) 233–248

Phillips, P., see Zhang, Y. (4) 1163–1179

Piazza, F., see Carmona-Iragui, M. (1) 1–7

Piccininni, C., see Marra, C. (1) 61–70

Piguet, O., see Dermody, N. (2) 425–441

Pinessi, L., see Oldoni, E. (2) 353–357

Piras, F., see Spalletta, G. (3) 807–816

Piras, F., see Spalletta, G. (3) 807–816

Piscopo, P., see Oldoni, E. (2) 353–357

Pistono, A., M. Jucla, E.J. Barbeau, L. Saint-Aubert, B. Lemesle, B. Calvet, B. Köpke, M. Puel and J. Pariente, Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer’s Disease (3) 687–698

Plitman, E., see Nagata, T. (3) 839–845

Pocchiari, M., see Baiardi, S. (2) 465–476

Politi, L.E., see Fernández, G. (3) 827–838

Polynice, S., see Santos, C.Y. (1) 127–131

Ponzo, V., see Koch, G. (2) 605–616

Porter, T., P. Bharadwaj, D. Groth, A. Paxman, S.M. Laws, R.N. Martins and G. Verdile, The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity (3) 895–905

Postacchini, D., see Balietti, M. (4) 957–962

Pradeep, V.G., see Wang, N. (3) 699–707

Pradier, L., see Weissmann, R. (2) 397–409

Praino, F., see Malara, A. (4) 1217–1225

Puel, M., see Pistono, A. (3) 687–698

Qi, D., see Zhang, T. (2) 455–463

Qian, W., see Fischer, C.E. (1) 283–295

Qiao, Z., see Shi, S. (3) 859–871

Qiu, C., see Wimo, A. (2) 387–396

Qiu, H., R. Zhong, H. Liu, F. Zhang, S. Li and W. Le, Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer’s Disease-Like Pathologies in AβPPswe/PS1ΔE9 Mice (3) 669–685

Qiu, T., see Luo, X. (4) 1137–1148

Quaranta, D., see Marra, C. (1) 61–70

Quelch, W., see Vallortigara, J. (1) 101–110

Quintana-Hernández, D.J., M.T. Miró-Barrachina, I.J. Ibáñez-Fernández, A. Santana-del Pino, M.P. Quintana-Montesdeoca, B. Rodríguez-de Vera, D. Morales-Casanova, M. del Carmen Pérez-Vieitez, J. Rodríguez-García and N. Bravo-Caraduje, Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer’s Disease: A Randomized Clinical Trial (1) 217–232

Quintana-Montesdeoca, M.P., see Quintana-Hernández, D.J. (1) 217–232

Rábano, A., see Bolós, M. (1) 77–87

Rabinovich-Nikitin, I., see Ezra, A. (1) 175–188

Rabinovich-Toidman, P., see Ezra, A. (1) 175–188

Rainero, I., see Oldoni, E. (2) 353–357

Rainey-Smith, S.R., see Gardener, S.L. (2) 301–334

Ramassamy, C., see Belkacemi, A. (4) 981–998

Ramirez, M.J., see Rodriguez-Perdigon, M. (4) 963–967

Ranson, J.M., see Kuźma, E. (4) 1099–1108

Ray, S.K., see Chakrabarti, M. (2) 335–352

Reed, J.W., see Chakrabarti, M. (2) 335–352

Refsum, H., see Oulhaj, A. (2) 547–557

Renard, D., A. Wacongne, X. Ayrignac, M. Charif, G. Fourcade, S. Azakri, A. Le Floch, S. Bouly, C. Marelli, C. Arquizan, C. Hirtz, A. Gabelle, E. Thouvenot and S. Lehmann, Cerebrospinal Fluid Alzheimer’s Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation (3) 759–764

Rhodius-Meester, H.F.M., J. Koikkalainen, J. Mattila, C.E. Teunissen, F. Barkhof, A.W. Lemstra, P. Scheltens, J. Lötjönen and W.M. van der Flier, Integrating Biomarkers for Underlying Alzheimer’s Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers (1) 261–270

Ribosa-Nogué, R., see Morenas-Rodríguez, E. (2) 539–546

Richards, A.M., see Lim, S.L. (1) 27–40

Rispoli, V., see Malara, A. (4) 1217–1225

Robert, P., see Sacco, G. (1) 19–25

Rodríguez-de Vera, B., see Quintana-Hernández, D.J. (1) 217–232

Rodríguez-García, J., see Quintana-Hernández, D.J. (1) 217–232

Rodriguez-Perdigon, M., M. Solas and M.J. Ramirez, JNK: A Putative Link Between Insulin Signaling and VGLUT1 in Alzheimer’s Disease (4) 963–967

Roher, A.E., C.L. Maarouf and T.A. Kokjohn, Familial Presenilin Mutations and Sporadic Alzheimer’s Disease Pathology: Is the Assumption of Biochemical Equivalence Justified? (3) 645–658

Rohrer, J.D., see Hardy, C.J.D. (2) 359–371

Rongioletti, M., see Siotto, M. (4) 1181–1189

Rongve, A., see Vijayaraghavan, S. (2) 567–576

Roorda, J.J., see Claus, J.J. (3) 797–806

Rossini,P.M., see Siotto, M. (4) 1181–1189

Rotstein, N.P., see Fernández, G. (3) 827–838

Rouleau, I., see Langlois, R. (4) 1023–1033

Rowley, H.A., see Melah, K.E. (3) 873–886

Rubino, E., see Oldoni, E. (2) 353–357

Ruggiero, C., see Boccardi, V. (4) 947–955

Ruíz, A., see Ibarria, M. (2) 559–566

Sacco, G., C. Caillaud, G.B. Sadoun, P. Robert, R. David and J. Brisswalter, Exercise Plus Cognitive Performance Over and Above Exercise Alone in Subjects with Mild Cognitive Impairment (1) 19–25

Sadoun, G.B., see Sacco, G. (1) 19–25

Sager, M.A., see Melah, K.E. (3) 873–886

Saint-Aubert, L., see Eustache, P. (4) 1035–1050

Saint-Aubert, L., see Pistono, A. (3) 687–698

Sala, I., see Carmona-Iragui, M. (1) 1–7

Sala, I., see Morenas-Rodríguez, E. (2) 539–546

Sampedro, F., see Carmona-Iragui, M. (1) 1–7

Sancesario, G., see Spalletta, G. (3) 807–816

Sánchez-Benavides, G., see Gramunt, N. (4) 999–1010

Sánchez-Ferro, A., see Bermejo-Pareja, F. (3) 719–731

Sánchez-Saudinós, M.B., see Morenas-Rodríguez, E. (2) 539–546

Sando, S.B., see Vijayaraghavan, S. (2) 567–576

Santana-del Pino, A., see Quintana-Hernández, D.J. (1) 217–232

Santangelo, M., see Baiardi, S. (2) 465–476

Santos, C.Y., Y.Y. Lim, W.-C. Wu, J.T. Machan, S. Polynice, R. Schindler, P. Maruff and P.J. Snyder, Resting-State Cardiac Workload is Related to Both Increased Neocortical Aggregation of Amyloid-β and Relative Impairments in Spatial Working Memory in Pre-Clinical Alzheimer’s Disease (1) 127–131

Satsu, H., see Hisatsune, T. (1) 149–159

Scaricamazza, E., see Marra, C. (1) 61–70

Scarioni, M., see Oldoni, E. (2) 353–357

Scarpini, E., see Oldoni, E. (2) 353–357

Scheltens, P., see Claus, J.J. (3) 797–806

Scheltens, P., see Rhodius-Meester, H.F.M. (1) 261–270

Schindler, R., see Santos, C.Y. (1) 127–131

Schmaderer, C., see Tholen, S. (3) 791–796

Schneider, L.S., see Kennedy, R.E. (4) 1205–1215

Schoenfeld, R., see Kleinschmidt, M. (1) 111–126

Schröter, F., see Wruck, W. (4) 1065–1082

Schuck, F., D. Wolf, A. Fellgiebel and K. Endres, Increase of α-Secretase ADAM10 in Platelets Along Cognitively Healthy Aging (3) 817–826

Schultz, A.P., see Malishkevich, A. (1) 249–260

Schumacher, M., see Fernández, G. (3) 827–838

Schuurmans, L., see Claus, J.J. (3) 797–806

Schweizer, T.A., see Fischer, C.E. (1) 283–295

Segura, L., see Bartolotti, N. (2) 477–489

Seo, S.W., see Jung, N.-Y. (4) 1125–1135

Seo, S.W., see Kim, H.J. (3) 709–718

Seong, J.-K., see Jung, N.-Y. (4) 1125–1135

Serpente, M., see Oldoni, E. (2) 353–357

Serra, L., see Makovac, E. (2) 591–604

Seshadri, S., see Lebowitz, B.K. (1) 41–45

Settembrini, V., see Malara, A. (4) 1217–1225

Sgrò, G., see Malara, A. (4) 1217–1225

Sha, S., see Jin, H. (2) 501–516

Shang, Y., see Huang, F. (3) 659–667

Shelton, P., see Fischer, C.E. (1) 283–295

Shen, L., see Gao, L. (1) 13–17

Shen, Z., see Luo, X. (4) 1137–1148

Shi, S., D. Liang, M. Bao, Y. Xie, W. Xu, L. Wang, Z. Wang and Z. Qiao, Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways (3) 859–871

Shin, J.S., see Kim, H.J. (3) 709–718

Shinagawa, S., see Nagata, T. (3) 839–845

Shui, G., see Chatterjee, P. (3) 887–894

Siersma, V., see Hoffmann, K. (2) 443–453

Šimić, G., see Babić Leko, M. (3) 765–778

Simonelli, I., see Siotto, M. (4) 1181–1189

Simons, K., see Maes, A. (3) 741–749

Siotto, M., I. Simonelli, P. Pasqualetti, S. Mariani, D. Caprara, S. Bucossi, M. Ventriglia, R. Molinario, M. Antenucci, M. Rongioletti, P.M. Rossini and R. Squitti, Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer’s Disease (4) 1181–1189

Sjölund, B.-M., see Wimo, A. (2) 387–396

Sköldunger, A., see Wimo, A. (2) 387–396

Slowik, A., see Dziedzic, T. (3) 623–644

Smith, A.D., see Oulhaj, A. (2) 547–557

Smith, E.E., see Fischer, C.E. (1) 283–295

Snowden, S.G., see Chatterjee, P. (3) 887–894

Snyder, P.J., see Santos, C.Y. (1) 127–131

Sobol, N.A., see Hoffmann, K. (2) 443–453

Sohrabi, H.R., see Chatterjee, P. (3) 887–894

Solas, M., see Rodriguez-Perdigon, M. (4) 963–967

Solomon, B., see Ezra, A. (1) 175–188

Song, R., see Luo, X. (4) 1137–1148

Soni, M., see Kuźma, E. (4) 1099–1108

Sorbi, S., see Oldoni, E. (2) 353–357

Spadea, F., see Malara, A. (4) 1217–1225

Spagnolo, P., see Gallucci, M. (4) 969–979

Spalletta, G., L. Cravello, W. Gianni, F. Piras, M. Iorio, C. Cacciari, A.R. Casini, C. Chiapponi, G. Sancesario, C. Fratangeli, M.D. Orfei, C. Caltagirone and F. Piras, Homotaurine Effects on Hippocampal Volume Loss and Episodic Memory in Amnestic Mild Cognitive Impairment (3) 807–816

Spanò, B., see Makovac, E. (2) 591–604

Spence, J.S., see Mudar, R.A. (2) 577–590

Sperling, R.A., see Malishkevich, A. (1) 249–260

Squitti, R., see Siotto, M. (4) 1181–1189

Staekenborg, S.S., see Claus, J.J. (3) 797–806

Steenland, K., F.C. Goldstein, A. Levey and W. Wharton, A Meta-Analysis of Alzheimer’s Disease Incidence and Prevalence Comparing African-Americans and Caucasians (1) 71–76

Steubl, D., see Tholen, S. (3) 791–796

Stevens, M., see Claus, J.J. (3) 797–806

Stockburger, C., D. Miano, M. Baeumlisberger, T. Pallas, T.N. Arrey, M. Karas, K. Friedland and W.E. Müller, A Mitochondrial Role of SV2a Protein in Aging and Alzheimer’s Disease: Studies with Levetiracetam (1) 201–215

Strumia, S., see Baiardi, S. (2) 465–476

Sugawara, Y., see Sugiyama, K. (2) 491–500

Sugiyama, K., Y. Tomata, Y. Kaiho, K. Honkura, Y. Sugawara and I. Tsuji, Association between Coffee Consumption and Incident Risk of Disabling Dementia in Elderly Japanese: The Ohsaki Cohort 2006 Study (2) 491–500

Sung, H., see Lim, S. (1) 189–200

Su-Ping Lam, C., see Lim, S.L. (1) 27–40

Taddei, K., see Chatterjee, P. (3) 887–894

Takahashi, S., K. Mizukami, T. Arai, R. Ogawa, N. Kikuchi, S. Hattori, D. Darby and T. Asada, Ventilatory Response to Hypercapnia Predicts Dementia with Lewy Bodies in Late-Onset Major Depressive Disorder (3) 751–758

Talarico, G., see Oldoni, E. (2) 353–357

Tan, L., see Wang, J. (4) 927–945

Tan, X., see Huang, F. (3) 659–667

Tantinyá, N., see Ibarria, M. (2) 559–566

Tárraga, L., see Ibarria, M. (2) 559–566

Terasawa, T., see Mishima, A. (1) 161–174

Teunissen, C.E., see Rhodius-Meester, H.F.M. (1) 261–270

Tholen, S., C. Schmaderer, S. Chmielewski, H. Förstl, U. Heemann, M. Baumann, D. Steubl and T. Grimmer, Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy? (3) 791–796

Thomas, A., see Vallortigara, J. (1) 101–110

Thouvenot, E., see Renard, D. (3) 759–764

Thyrian, J.R., see Michalowsky, B. (1) 47–59

Tielkes, C.E.M., see Claus, J.J. (3) 797–806

Tomata, Y., see Sugiyama, K. (2) 491–500

Tong, M., see Deochand, C. (2) 373–386

Tong, M., see Yu, R. (1) 133–148

Torso, M., see Makovac, E. (2) 591–604

Totsuka, M., see Hisatsune, T. (1) 149–159

Trincado, R., see Bermejo-Pareja, F. (3) 719–731

Trzepacz, P.T., see Hochstetler, H. (1) 271–282

Tseng, W.-Y.I., see Chang, Y.-L. (2) 411–423

Tsuji, I., see Sugiyama, K. (2) 491–500

Ukoumunne, O.C., see Kuźma, E. (4) 1099–1108

Ulstein, I.D., see Vijayaraghavan, S. (2) 567–576

Valero, S., see Ibarria, M. (2) 559–566

Vallortigara, J., D. Whitfield, W. Quelch, A. Alghamdi, D. Howlett, T. Hortobágyi, M. Johnson, J. Attems, J.T. O’Brien, A. Thomas, C.G. Ballard, D. Aarsland and P.T. Francis, Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia (1) 101–110

van der Flier, W.M., see Rhodius-Meester, H.F.M. (1) 261–270

van Maarschalkerweerd, W., see Claus, J.J. (3) 797–806

van Schoor, N.M., see Kuźma, E. (4) 1099–1108

Varley, R.A., see Hardy, C.J.D. (2) 359–371

Ventriglia, M., see Siotto, M. (4) 1181–1189

Vera, M., see Ibarria, M. (2) 559–566

Verdile, G., see Porter, T. (3) 895–905

Verghese, J., see Wang, N. (3) 699–707

Verschaeve, L., see Maes, A. (3) 741–749

Vestergaard, K., see Hoffmann, K. (2) 443–453

Vijayaraghavan, S., T. Darreh-Shori, A. Rongve, G. Berge, S.B. Sando, L.R. White, B.H. Auestad, A. Witoelar, O.A. Andreassen, I.D. Ulstein and D. Aarsland, Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer’s Disease (2) 567–576

Vilaplana, E., see Morenas-Rodríguez, E. (2) 539–546

Vogel, A., see Hoffmann, K. (2) 443–453

von Strauss, E., see Wimo, A. (2) 387–396

Wacongne, A., see Renard, D. (3) 759–764

Waldemar, G., see Hoffmann, K. (2) 443–453

Wambacq, S., see Maes, A. (3) 741–749

Wan, Q., see Jin, H. (2) 501–516

Wang, C., see Jin, H. (2) 501–516

Wang, G., see Kennedy, R.E. (4) 1205–1215

Wang, J., L. Tan and J.-t. Yu, Prevention Trials in Alzheimer’s Disease: Current Status and Future Perspectives (4) 927–945

Wang, L., see Shi, S. (3) 859–871

Wang, N., G. Allali, C. Kesavadas, M.L. Noone, V.G. Pradeep, H.M. Blumen and J. Verghese, Cerebral Small Vessel Disease and Motoric Cognitive Risk Syndrome: Results from the Kerala-Einstein Study (3) 699–707

Wang, N., see Zhang, T. (2) 455–463

Wang, S., see Hochstetler, H. (1) 271–282

Wang, S., see Zhang, Y. (4) 1163–1179

Wang, S., see Zhu, M. (4) 1149–1162

Wang, S., Y. Zhang, G. Liu, P. Phillips and T.-F. Yuan, Detection of Alzheimer’s Disease by Three-Dimensional Displacement Field Estimation in Structural Magnetic Resonance Imaging (1) 233–248

Wang, Z., see Shi, S. (3) 859–871

Warren, J.D., see Hardy, C.J.D. (2) 359–371

Warrington, E.K., see Hardy, C.J.D. (2) 359–371

Weinstein, C., see Lebowitz, B.K. (1) 41–45

Weissmann, R., M. Hüttenrauch, T. Kacprowski, Y. Bouter, L. Pradier, T.A. Bayer, A.W. Kuss and O. Wirths, Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer’s Disease (2) 397–409

Wenk, M.R., see Chatterjee, P. (3) 887–894

Wermuth, L., see Hoffmann, K. (2) 443–453

Wharton, W., see Steenland, K. (1) 71–76

White, L.R., see Vijayaraghavan, S. (2) 567–576

Whitfield, D., see Vallortigara, J. (1) 101–110

Wimo, A., B.-M. Sjölund, A. Sköldunger, C. Qiu, I. Klarin, G. Nordberg and E. von Strauss, Cohort Effects in the Prevalence and Survival of People with Dementia in a Rural Area in Northern Sweden (2) 387–396

Wirths, O., see Weissmann, R. (2) 397–409

Witkowski, J.M., see Bourgade, K. (4) 1227–1241

Witoelar, A., see Vijayaraghavan, S. (2) 567–576

Wolf, D., see Schuck, F. (3) 817–826

Wolf, P.A., see Lebowitz, B.K. (1) 41–45

Wruck, W., F. Schröter and J. Adjaye, Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer’s Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks (4) 1065–1082

Wu, J., see Zhu, M. (4) 1149–1162

Wu, P., see Huang, F. (3) 659–667

Wu, R., see Zhu, M. (4) 1149–1162

Wu, W., see Ni, L. (4) 1243–1254

Wu, W.-C., see Santos, C.Y. (1) 127–131

Wucherer, D., see Michalowsky, B. (1) 47–59

Xie, C., see Zhu, M. (4) 1149–1162

Xie, W., see Zhu, M. (4) 1149–1162

Xie, Y., see Shi, S. (3) 859–871

Xiong, C., see Chatterjee, P. (3) 887–894

Xu, W., see Shi, S. (3) 859–871

Xu, X., see Luo, X. (4) 1137–1148

Xu, Y., see Ni, L. (4) 1243–1254

Yamashita, S., T. Kiko, H. Fujiwara, M. Hashimoto, K. Nakagawa, M. Kinoshita, K. Furukawa, H. Arai and T. Miyazawa, Alterations in the Levels of Amyloid-β, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer’s Disease: Possible Interactions between Amyloid-β and These Lipids (2) 527–537

Yan, S.-H., see Chang, Y.-L. (2) 411–423

Yang, J., see Zhang, Y. (4) 1163–1179

Yang, X., see Zhu, M. (4) 1149–1162

Yasue, I., S. Matsunaga, T. Kishi, K. Fujita and N. Iwata, Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson’s Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators (3) 733–740

Yen, Y.-S., see Chang, Y.-L. (2) 411–423

Yew, B., see Nation, D.A. (3) 779–789

Yin, Z., see Ni, L. (4) 1243–1254

Yoo, S.W., see Jung, N.-Y. (4) 1125–1135

Yu, H., see Ni, L. (4) 1243–1254

Yu, J.-t., see Wang, J. (4) 927–945

Yu, P., see Hochstetler, H. (1) 271–282

Yu, R., C. Deochand, A. Krotow, R. Leão, M. Tong, A.R. Agarwal, E. Cadenas and S.M. de la Monte, Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration (1) 133–148

Yu, X., see Luo, X. (4) 1137–1148

Yuan, T.-F., see Wang, S. (1) 233–248

Yuan, T.-F., see Zhang, Y. (4) 1163–1179

Yuan-Fu Lu, S., see Melah, K.E. (3) 873–886

Zetterberg, H., see Melah, K.E. (3) 873–886

Zhang, B., see Jin, H. (2) 501–516

Zhang, B., see Ni, L. (4) 1243–1254

Zhang, F., see Qiu, H. (3) 669–685

Zhang, J., see Zhang, T. (2) 455–463

Zhang, M., see Luo, X. (4) 1137–1148

Zhang, T., H. Li, J. Zhang, X. Li, D. Qi, N. Wang and Z. Zhang, Impacts of High Serum Total Cholesterol Level on Brain Functional Connectivity in Non-Demented Elderly (2) 455–463

Zhang, X., see Ni, L. (4) 1243–1254

Zhang, Y., S. Wang, P. Phillips, J. Yang and T.-F. Yuan, Three-Dimensional Eigenbrain for the Detection of Subjects and Brain Regions Related with Alzheimer’s Disease (4) 1163–1179

Zhang, Y., see Wang, S. (1) 233–248

Zhang, Z., see Zhang, T. (2) 455–463

Zhao, H., see Ni, L. (4) 1243–1254

Zhen, L., see Huang, F. (3) 659–667

Zhong, C., see Zhu, M. (4) 1149–1162

Zhong, R., see Qiu, H. (3) 669–685

Zhou, F., see Ni, L. (4) 1243–1254

Zhu, B., see Ni, L. (4) 1243–1254

Zhu, J., see Zhu, M. (4) 1149–1162

Zhu, M., C. Huang, X. Ma, R. Wu, W. Zhu, X. Li, Z. Liang, F. Deng, J. Zhu, W. Xie, X. Yang, Y. Jiang, S. Wang, J. Wu, S. Geng, C. Xie and C. Zhong, Modulation of miR-19 in Aluminum-Induced Neural Cell Apoptosis (4) 1149–1162

Zhu, W., see Zhu, M. (4) 1149–1162

Zimmerer, V.C., see Hardy, C.J.D. (2) 359–371